Article Details
Retrieved on: 2018-01-07 11:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Infosys</b> just saw through one of its worst recent years. Has potential of completing strategic retooling and improve capital allocation. ... <b>Infosys</b> is top pick for 2018 given reasonable earnings growth and rerating potential. HSBC on Biocon: Maintains Hold; raised price target to Rs536 from Rs320.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here